Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Evaluation and treatment of postmenopausal osteoporosis Wang CY; Bruder JM; Rubin CDAm J Manag Care 2001[Sep]; 7 Spec No (ä): SP5-16Osteoporosis is a prevalent condition among elderly women and is associated with an increased risk for fractures. With the burgeoning size of the elderly population, a practitioner is likely to face many questions regarding the evaluation and management of postmenopausal osteoporosis. This review discusses and compares available therapies. All women should have adequate calcium and vitamin D intake. Women diagnosed as having osteoporosis should be evaluated for secondary causes of osteoporosis and risk factors for falls. For women with postmenopausal osteoporosis, therapy with hormone replacement, bisphosphonates (alendronate sodium or risedronate sodium), raloxifene hydrochloride, or calcitonin should be considered. The results of ongoing studies will help refine the strategies used for management of postmenopausal osteoporosis.|*Postmenopause[MESH]|*Women's Health[MESH]|Aged[MESH]|Algorithms[MESH]|Bone Density[MESH]|Calcitonin/administration & dosage[MESH]|Calcium/administration & dosage[MESH]|Diphosphonates/administration & dosage[MESH]|Estrogens/administration & dosage[MESH]|Female[MESH]|Fractures, Bone/etiology[MESH]|Humans[MESH]|Osteoporosis/complications/*diagnosis/*drug therapy/physiopathology[MESH]|Raloxifene Hydrochloride/administration & dosage[MESH]|Risk Factors[MESH]|Selective Estrogen Receptor Modulators/administration & dosage[MESH]|United States/epidemiology[MESH] |